LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 49.63 | 27.76 | 1378 | 4818 | 0.2860 | 0.6903 | MN20160318_Q01 | H06 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 49.63 | 27.76 | 436 | 4818 | 0.0905 | 0.4480 | MN20160318_Q01 | M14 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 49.63 | 27.76 | 1780 | 4818 | 0.3694 | 0.7494 | MN20160318_Q01 | M14 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 51.33 | 27.76 | 1480 | 5117 | 0.2892 | 0.6961 | MN20160318_Q01 | H06 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 51.33 | 27.76 | 1507 | 5117 | 0.2945 | 0.7002 | MN20160318_Q01 | H06 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 51.33 | 27.76 | 492 | 5117 | 0.0961 | 0.4652 | MN20160318_Q01 | M14 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 51.33 | 27.76 | 1871 | 5117 | 0.3656 | 0.7497 | MN20160318_Q01 | M14 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 53.04 | 27.76 | 1497 | 5365 | 0.2790 | 0.6906 | MN20160318_Q01 | H06 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 53.04 | 27.76 | 1524 | 5365 | 0.2840 | 0.6945 | MN20160318_Q01 | H06 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 53.04 | 27.76 | 546 | 5365 | 0.1018 | 0.4803 | MN20160318_Q01 | M14 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 53.04 | 27.76 | 1946 | 5365 | 0.3627 | 0.7500 | MN20160318_Q01 | M14 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 54.74 | 27.76 | 1583 | 5606 | 0.2824 | 0.6956 | MN20160318_Q01 | H06 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 54.74 | 27.76 | 1607 | 5606 | 0.2866 | 0.6989 | MN20160318_Q01 | H06 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 54.74 | 27.76 | 592 | 5606 | 0.1056 | 0.4912 | MN20160318_Q01 | M14 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 54.74 | 27.76 | 1880 | 5606 | 0.3353 | 0.7341 | MN20160318_Q01 | M14 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 56.45 | 27.76 | 1557 | 5745 | 0.2710 | 0.6878 | MN20160318_Q01 | H06 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 56.45 | 27.76 | 1576 | 5745 | 0.2743 | 0.6905 | MN20160318_Q01 | H06 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 56.45 | 27.76 | 627 | 5745 | 0.1091 | 0.4996 | MN20160318_Q01 | M14 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 56.45 | 27.76 | 2060 | 5745 | 0.3586 | 0.7504 | MN20160318_Q01 | M14 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 58.15 | 27.76 | 1619 | 5906 | 0.2741 | 0.6918 | MN20160318_Q01 | H06 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 58.15 | 27.76 | 1642 | 5906 | 0.2780 | 0.6949 | MN20160318_Q01 | H06 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 58.15 | 27.76 | 660 | 5906 | 0.1117 | 0.5064 | MN20160318_Q01 | M14 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 58.15 | 27.76 | 2106 | 5906 | 0.3566 | 0.7503 | MN20160318_Q01 | M14 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 59.85 | 27.76 | 1717 | 6062 | 0.2832 | 0.7003 | MN20160318_Q01 | H06 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 59.85 | 27.76 | 1744 | 6062 | 0.2877 | 0.7037 | MN20160318_Q01 | H06 |